<div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <p>Consano Bio raises $15M Series A+ led by Conviction.</p><p>Participants in this funding round include various investors eager to support advancements in healthcare.</p><p>Consano Bio develops therapeutics designed to address serious, painful orthopedic conditions. The company is led by CEO Andrew Hall.</p><table class="vc-deal-terms"><tbody><tr><th>Company</th><td>Consano Bio</td></tr><tr><th>Amount</th><td>$15M</td></tr><tr><th>Founders</th><td>Andrew Hall, Conviction Andrew Hall</td></tr><tr><th>Sectors</th><td>Biotechnology</td></tr></tbody></table>
</div>
</div>
</div>


<div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <p>Consano Bio raises <strong>$15M</strong> Series A+ led by <a href="/company/conviction/">Conviction</a>.</p>
<p>Participants in this funding round include various investors eager to support advancements in healthcare.</p>
<p>Consano Bio develops therapeutics designed to address serious, painful orthopedic conditions. The company is led by CEO Andrew Hall.</p>
<table class="vc-deal-terms"><tbody>
<tr>
<th>Company</th>
<td>Consano Bio</td>
</tr>
<tr>
<th>Amount</th>
<td><strong>$15M</strong></td>
</tr>
<tr>
<th>Founders</th>
<td>Andrew Hall, <a href="/company/conviction/">Conviction</a> Andrew Hall</td>
</tr>
<tr>
<th>Sectors</th>
<td>Biotechnology</td>
</tr>
</tbody></table>
</div>
</div>
</div>


Consano Bio Raises $15M

Consano Bio Raises $15M | Traded VC

ABOUT THIS STORY

<div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <p>Consano Bio raises <strong>$15M</strong> Series A+ led by <a href="/company/conviction/">Conviction</a>.</p>
<p>Participants in this funding round include various investors eager to support advancements in healthcare.</p>
<p>Consano Bio develops therapeutics designed to address serious, painful orthopedic conditions. The company is led by CEO Andrew Hall.</p>
<table class="vc-deal-terms"><tbody>
<tr>
<th>Company</th>
<td>Consano Bio</td>
</tr>
<tr>
<th>Amount</th>
<td><strong>$15M</strong></td>
</tr>
<tr>
<th>Founders</th>
<td>Andrew Hall, <a href="/company/conviction/">Conviction</a> Andrew Hall</td>
</tr>
<tr>
<th>Sectors</th>
<td>Biotechnology</td>
</tr>
</tbody></table>
</div>
</div>
</div>

Consano Bio Raises $15M

ABOUT THIS STORY

Inside 645 Ventures: The firm's approach to Contrarian Investing, AI, Fintech and Founder-First Bets

Darren Bechtel Bet Big on Construction Tech Before Anyone Cared

Daytona Raises $60M at $1B Valuation

Company	Consano Bio
Amount	$15M
Founders	Andrew Hall, Conviction Andrew Hall
Sectors	Biotechnology

Consano Bio Raises $15M

ABOUT THIS STORY

More articles

Inside 645 Ventures: The firm's approach to Contrarian Investing, AI, Fintech and Founder-First Bets

Darren Bechtel Bet Big on Construction Tech Before Anyone Cared

Daytona Raises $60M at $1B Valuation